Meprate Tablet is a female hormone known as progestin (a form of progesterone) that regulates ovulation (the release of an egg from an ovary). It treats the absence of menstrual periods (amenorrhea) and abnormal uterine bleeding. Besides this, it also prevents endometrial hyperplasia (thickening of the uterine lining with the risk of cancer) and overgrowth in the lining of the uterus in postmenopausal women who are receiving estrogen hormone replacement therapy.

Meprate Tablet contains medroxyprogesterone. Meprate Tablet works by replacing the normal hormone medroxyprogesterone functions in the body and treating associated symptoms.

Your doctor will advise your dose and how often you need to take this medication based on your medical condition. You may sometimes have breast tenderness, swelling in other body parts, headaches, migraines, mood swings, depression, acne, tummy (abdominal) pain, back pain, and vaginal bleeding. Most of these side effects of Meprate Tablet do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Try not to stop taking this medicine of your own. Using Meprate Tablet may increase the risk of blood clots. Make sure that before taking this medicine, you inform your doctor if you have or have had breast cancer, unusual bleeding in the vagina, liver disease, or any other health problems. If you are taking any other medicine or are allergic to any medication, please inform your doctor. Avoid smoking and alcohol to prevent any kind of unpleasant side-effect. Meprate Tablet should not be used in heart disease or dementia patients because this medicine may increase your risk of developing these conditions.

Swallow it as a whole with water; do not crush, break or chew it.

Meprate Tablet is a female hormone that regulates ovulation and menstruation in women. Meprate Tablet helps in initiating the menses cycle (periods) in women who have not yet reached menopause. Besides this, it prevents overgrowth of the uterus in postmenopausal women who take estrogen as hormone replacement therapy (HRT). Meprate Tablet is used to prevent thickening of the uterine lining in postmenopausal women receiving estrogens who have not removed their uterus through surgery. It also helps treat amenorrhea (cessation or irregular menses cycle for more than three months). It is also given in combination with estrogens as part of menopausal replacement therapy. The injection form of Meprate Tablet is prescribed for treating abnormal uterine bleeding along with irregular or ceased menstrual cycles. The intravaginal gel form of Meprate Tablet assists in reproductive technology for infertile women with progesterone deficiency or irregular or ceased menstrual cycle. The vaginal insert form of Meprate Tablet supports early pregnancy and implantation of an embryo in the uterus. Off-label use of Meprate Tablet helps in reducing the risk of preterm birth.

Meprate Tablet with estrogen should not be used to prevent heart disease, heart attacks, strokes, or dementia. Using Meprate Tablet with estrogen may increase the chance of getting heart attacks, strokes, breast cancer, and blood clots. In some cases, using Meprate Tablet with estrogen may produce dementia among women aged 65 and older. Do not use Meprate Tablet if you are allergic to peanuts, have unusual vaginal bleeding, have had any cancer (breast or uterus cancer), or undergoing estrogen plus progestin treatment. Tell your doctor before using Meprate Tablet if you have had a heart attack, stroke, blood clot, liver problems, kidney problems, are pregnant, breastfeeding or planning to get pregnant, asthma (wheezing), epilepsy (seizures), diabetes, migraine, endometriosis, lupus, heart problems, thyroid, or have high calcium levels in your blood. Use caution while driving a motor vehicle, as dizziness or drowsiness may occur. Tell your doctor about this if you use Meprate Tablet before lab tests or biopsies, as it can affect the report values. Diagnostic tests of blood coagulation, thyroid, cholesterol, and glucose metabolism results might affect people using Meprate Tablet .